BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 18370310)

  • 1. Human body fluid proteome analysis.
    Hu S; Loo JA; Wong DT
    Proteomics; 2006 Dec; 6(23):6326-53. PubMed ID: 17083142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanopore film based enrichment and quantification of low abundance hepcidin from human bodily fluids.
    Fan J; Niu S; Dong A; Shi J; Wu HJ; Fine DH; Tian Y; Zhou C; Liu X; Sun T; Anderson GJ; Ferrari M; Nie G; Hu Y; Zhao Y
    Nanomedicine; 2014 Jul; 10(5):879-88. PubMed ID: 24566273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers discovery by peptide and protein profiling in biological fluids based on functionalized magnetic beads purification and mass spectrometry.
    Magni F; Van Der Burgt YE; Chinello C; Mainini V; Gianazza E; Squeo V; Deelder AM; Kienle MG
    Blood Transfus; 2010 Jun; 8 Suppl 3(Suppl 3):s92-7. PubMed ID: 20606758
    [No Abstract]   [Full Text] [Related]  

  • 4. Resampling and deconvolution of linear time-of-flight records for enhanced protein profiling.
    Malyarenko DI; Cooke WE; Tracy ER; Drake RR; Shin S; Semmes OJ; Sasinowski M; Manos DM
    Rapid Commun Mass Spectrom; 2006; 20(11):1670-8. PubMed ID: 16637003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of diagnostic upper gastrointestinal cancer tissue type-specific urinary biomarkers.
    Husi H; Fernandes M; Skipworth RJ; Miller J; Cronshaw AD; Fearon KCH; Ross JA
    Biomed Rep; 2019 Mar; 10(3):165-174. PubMed ID: 30906545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges for biomarker discovery in body fluids using SELDI-TOF-MS.
    De Bock M; de Seny D; Meuwis MA; Chapelle JP; Louis E; Malaise M; Merville MP; Fillet M
    J Biomed Biotechnol; 2010; 2010():906082. PubMed ID: 20029632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast.
    Gromov P; Gromova I; Bunkenborg J; Cabezon T; Moreira JM; Timmermans-Wielenga V; Roepstorff P; Rank F; Celis JE
    Mol Oncol; 2010 Feb; 4(1):65-89. PubMed ID: 20005186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein profiling for cancer biomarker discovery using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and infrared imaging: a review.
    Bakry R; Rainer M; Huck CW; Bonn GK
    Anal Chim Acta; 2011 Mar; 690(1):26-34. PubMed ID: 21414433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarker discovery from body fluids using mass spectrometry.
    Villar-Garea A; Griese M; Imhof A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 849(1-2):105-14. PubMed ID: 17097359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface-enhanced laser desorption/ionization mass spectrometry for protein and Peptide profiling of body fluids.
    Gagnon A; Shi Q; Ye B
    Methods Mol Biol; 2008; 441():41-56. PubMed ID: 18370310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
    O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
    Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derivatized mesoporous silica beads for MALDI-TOF MS profiling of human plasma and urine.
    Terracciano R; Pasqua L; Casadonte F; Frascà S; Preianò M; Falcone D; Savino R
    Bioconjug Chem; 2009 May; 20(5):913-23. PubMed ID: 19338374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel approach using MALDI-TOF/TOF mass spectrometry and prestructured sample supports (AnchorChip Technology) for proteomic profiling and protein identification.
    Leung SM; Pitts RL
    Methods Mol Biol; 2008; 441():57-70. PubMed ID: 18370311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of biomarkers for breast cancer in nipple aspiration and ductal lavage fluid.
    Li J; Zhao J; Yu X; Lange J; Kuerer H; Krishnamurthy S; Schilling E; Khan SA; Sukumar S; Chan DW
    Clin Cancer Res; 2005 Dec; 11(23):8312-20. PubMed ID: 16322290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SELDI-TOF-MS of saliva: methodology and pre-treatment effects.
    Schipper R; Loof A; de Groot J; Harthoorn L; Dransfield E; van Heerde W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Feb; 847(1):45-53. PubMed ID: 17070117
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.